We present the case of a patient with malignant transformation of a liposclerosing myxofibrous tumor. The patient had a histologically confirmed liposclerosing myxofibrous tumor that, during a course of 22 months, spontaneously transformed into a lesion appearing like a benign giant cell reactive lesion and subsequently into a high-grade bone sarcoma. Few such cases of spontaneous malignant transformation of liposclerosing myxofibrous tumor have been reported. We report what we believe to be the first case documenting spontaneous transformation of a liposclerosing myxofibrous tumor into an intermediate lesion with benign-appearing histologic features and then into a high-grade malignant tumor.
Introduction
Liposclerosing myxofibrous tumor (LSMFT) is a benign fibroosseous bone lesion first described by Ragsdale and Sweet in 1986 [19] . It is a rare lesion thought to be related to fibrous dysplasia because of similarities in their histologic and radiographic features. An activating point mutation in the alpha subunit of a G protein has been identified in some LSMFT samples. This mutation is present in nearly all cases of polyostotic and monostotic fibrous dysplasia and provides additional evidence for this relationship [2, 6, 9, 13, 22] .
A LSMFT is usually an incidental finding. On average, it tends to affect patients in the fourth decade of life, occurring equally in males and females [11, 13, 18, 20] . It has a strong predilection for the proximal femur, and greater than 80% of cases arise in the intertrochanteric area of the femur [11, 17] . On radiographs, the characteristic appearance of a well-defined, geographic lytic lesion with sclerotic margins and mineralized matrix showing the indolent growth pattern of LSMFT usually is present [11, 17] . Histologically, it is characterized by a complex admixture of several histologic elements that may include myxofibrous tissue, lipomatous areas, fibrous dysplasialike bony trabeculae, cyst formation, fat necrosis, and ischemic ossification [6, 9, 11, 13, 17, 18, 20] .
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benign fibroosseous lesions has been described and is hypothesized to be related to these involutional and ischemic changes [11, 15] .
In this report, we describe a patient in whom a highgrade osteosarcoma developed at the site of a histologically confirmed LSMFT 22 months after her initial surgery. We observed progression of the LSMFT into a benign giant cell reactive lesion followed by subsequent degeneration into a malignant sarcomatous lesion.
Case Report
A 42-year-old woman was referred to our institution with a 1-month history of increasing pain in the left proximal thigh. Radiographs of the hip and femur taken by the referring physician showed a lytic geographic lesion with sclerotic margins filling the femoral neck and proximal intertrochanteric region with a central area of hazy matrix ( Fig. 1A ). Images taken at the time of our consultation confirmed a minimally displaced pathologic fracture of the left femoral neck had occurred in the interim. Computed tomography (CT) identified a large well-defined, geographic, lytic lesion with sclerotic margins in the left femoral neck region and a minimally displaced, unicortical, pathologic fracture ( Fig. 1B ). Curettage and cemented internal fixation of the femoral neck were performed and a diagnosis of LSMFT was made by correlating the imaging findings and histologic analysis of the curetted material ( Fig. 1C, D) . The histologic diagnosis was confirmed by outside review at a nationally recognized pathology referral center.
After an initially uncomplicated recovery, the patient began to experience hip pain 4 months after surgery. Plain film radiographs identified a nonunion of the femoral neck and cemented bipolar hemiarthroplasty was performed 5 months after the initial procedure. Histologic specimens from this procedure again confirmed the diagnosis of LSMFT. The patient had an uneventful recovery although she did report having intermittent hip pain.
One year after the initial and 7 months after the second surgery, the patient reported having pain again in the hip region. Followup radiographs showed a small area of lysis near the femoral calcar. Computed tomography-guided biopsy was performed of the region near the lesser trochanter ( Fig. 2A, B ). This now showed very different histologic features, consisting of abundant giant cells suggestive of a reactive process (Fig. 2C, D) . Some of the previous tissue findings were observed in the current specimen. Although there were infrequent mitotic figures (three per 10 high-power fields), these were not atypical and no other malignant features were seen.
Fourteen months after the initial surgery, the patient moved back to her native China for approximately 3 months. While there, she reported having worsening pain. We received only limited records from this period. A repeat surgery apparently was performed through a different, anterior approach. Radiographs taken on her return seem to show only the cerclage cables to have been removed. A presumptive diagnosis of malignancy seems to have been made as she was given one cycle of chemotherapy consisting of methotrexate and cisplatinum.
She returned to our institution 17 months after initial presentation with swelling and severe pain in her proximal thigh. Repeat radiographs showed extensive lysis of the proximal femoral metaphysis and CT scans showed an extraosseous anterior soft tissue mass that was contained by a thin rim of periosteum ( Fig. 3A, B ). Percutaneous CTguided biopsy now revealed abundant multinucleated giant cells surrounded by benign mononuclear cells, and again, no overt signs of malignancy. Computed tomography scans of the chest revealed no metastatic lesions. We performed resection of the entire proximal femur along with marginal resection of the soft tissue component and skeletal reconstruction with a segmental endoprosthetic prosthesis. Careful analysis of the resected specimen confirmed the biopsy results and again showed no overt signs of malignancy ( Fig. 3C, D) . The patient initially had an unremarkable recovery, returning to pain-free ambulation relatively rapidly.
However, after approximately 6 weeks, the patient again reported having pain and swelling in the proximal thigh. Within 2 months, a recurrent tumor had completely engulfed the patient's proximal thigh (Fig. 4A, B) , and the patient had severe and uncontrollable pain. A course of palliative radiotherapy (200 cGy/day) was attempted, but the patient's symptoms were progressing extremely rapidly. Treatment was aborted within 2 weeks, and a palliative hemipelvectomy was performed 22 months after initial presentation after repeat chest CT scans showed no pulmonary disease. The patient again recovered quickly and was independently ambulating with crutches and without pain. Histologic analysis of the amputation specimen now showed a few small regions of frank sarcomatous degeneration, some with osteoid formation (Fig. 4C, D) , leading to a diagnosis of secondary osteosarcoma.
Chemotherapy was discussed at this time, and although it seemed probable the patient eventually would have metastatic disease, there was no clear evidence to support that chemotherapy would delay this. We also considered the quality of the patient's remaining life and how it would be affected by chemotherapy. Three months after hemipelvectomy (25 months after initial presentation), pulmonary metastases developed and the patient died from her disease approximately 6 months after amputation.
Discussion
The exact time frame for the malignant transformation of LSMFT is not known. The typically slow growth of LSMFT suggests the process may occur over an extended time [11, [17] [18] [19] . The most common histologic patterns in transformed LSMFT include osteosarcoma, malignant fibrous histiocytoma, malignant fibroxanthomas, and high-grade spindle cell tumors [11, 17, 18] . The majority of reported transformations resulted in osteosarcoma, similar to what our patient experienced [24] . The unusual finding in our patient is evolution of a LSMFT into a transitional lesion, appearing as a benign giant cell reactive lesion, followed later by degeneration into a sarcomatous lesion, still with abundant giant cells. Our review of the literature failed to identify any similar cases.
There are few plausible explanations for the findings in this case. One is that a malignant lesion simply was misdiagnosed at the time of the first operation. However, the initial radiographic and histologic findings were not only consistent with each other but also reviewed and confirmed by outside consultants. Another possibility is that a second primary tumor, either a giant cell tumor or an osteosarcoma, arose at the same site. Although there have been numerous reports of spontaneous malignant transformation of giant cell tumors [1, 3, 4, 12, 21, 25] , the possibility of a second primary tumor occurring and then undergoing malignant transformation seems remote. A more likely explanation is that the intermediate benign giant cell tumor-like lesion observed was actually malignant but that the malignant portions simply were missed in the specimens from the percutaneous biopsy performed at approximately 1 year, and the resection performed 17 months after her initial presentation. Although it is hard to discount this potential, we were suspicious of malignancy with each recurrence and vigilant for this possibility. There is also the entity of giant cell-rich osteosarcoma, but the hallmark of that subtype of osteosarcoma is the presence of pleomorphic, even anaplastic, stromal cells in the setting of numerous giant cells, which did not match our findings [10] . Although there is a diagnostic error inherent in needle biopsies, Mitsuyoshi et al. [16] reported adequate cores for histologic diagnosis were obtained in 88% of the cases of musculoskeletal lesions they examined and a correct diagnosis of the malignancy and histology were identified in 97% of cases. Furthermore, they reported needle biopsies had an overall sensitivity of 100% and specificity of 90% for malignant musculoskeletal lesions. Therefore, the biopsy results combined with the histology from the resection samples which confirmed the biopsy results, makes the possibility that we missed the malignant lesion unlikely.
Our patient received radiation therapy during a 2-week period before the hemipelvectomy and it is known radiation can induce malignant transformation. However, radiation-induced malignant transformation typically has a latency period of 5 to 15 years, and thus this would seem an unlikely cause of the malignancy [5, 8, 14, 23] .
The risk of malignant transformation of LSMFT is reportedly as much as 10% to 16% [11, 18, 19] . These estimates may be a marked overestimate of the true risk because the lesion is usually an incidental finding, and there is an inherent bias in the consultative pathology series that gave rise to these figures [7, 9, 11, 17, 18] . Gilkey [7] noted in his experience with 40 cases at the Armed Forces Institute of Pathology, there was only one case in which a definite sarcoma accompanied a definite LSMFT, which adds some validity to claims that the current figures are an overestimation. Furthermore, the fact that LSMFT and fibrous dysplasia may be related suggests the risk of malignant transformation in LSMFT should be closer to the 0.5% risk of malignancy observed in fibrous dysplasia [9, 24] .
Despite the fact that the true risk of malignancy is not known, this case highlights the importance of close surveillance in patients with LSMFT. Although we generally select treatment for our patients on the basis of observed histology, in this case there was a wide discrepancy between the observed clinical behavior and the benign appearance of the histologic findings. Thus, we recommend clinicians maintain a high level of suspicion for malignancy in patients with LSMFT whose lesions behave aggressively or rapidly recur after surgical resection. In particular, a patient with a local recurrence reporting pain out of proportion to clinical findings should provoke an increased level of suspicion for malignant transformation and consideration for more complete resection than would normally be considered for a histologically benignappearing recurrent tumor.
